New Therapeutic Options Could Shift Prostate Cancer Treatment (APAC)

November 04, 2024

10:00 pm EST|

7:00 pm PST

November 05, 2024

11:00 am HKT|

3:00 am GMT

Duration: 60 Minutes

We will discuss the current prostate cancer treatments and key catalysts for older drugs facing loss of exclusivity. We will also discuss new therapies for prostate cancer, with protein degraders and T-cell engagers both aiming to hit the market in the near future.

Speakers

Max Nisen

Analyst

Bloomberg Intelligence

Sam Fazeli

Head of EMEA Research

Bloomberg

Register

First Name

Last Name

Company Name

Phone

Industry

Job Role

Country or Region

State or Province Optional

City

Would you like to be contacted by a Bloomberg representative to receive a free demo?

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

New Therapeutic Options Could Shift Prostate Cancer Treatment (APAC)

Speakers

Register

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.